Concepedia

Brenda Arnett

BA

7

Publications

422

Citations

7

H-Index

1999

Active since

Affiliations

Texas Oncology(Current)

Brenda Arnett is an author at Texas Oncology specializing in medicine, drug discovery, and molecular recognition.

Top concepts

Publications per year

1999–2003

7

Publications

7

Oxaliplatin-Induced Damage of Cellular DNA

Jan M. Woynarowski, Sandrine Faivre, Maryanne C. Herzig et al. · Molecular Pharmacology · 2000 · 298 citations

Drug uptake and cellular targets of hydroxymethylacylfulvene (HMAF)

Maryanne C. Herzig, Brenda Arnett, John R. MacDonald et al. · Biochemical Pharmacology · 1999 · 54 citations

, , +4

Region-Specific DNA Damage by AT-Specific DNA-Reactive Drugs Is Predicted by Drug Binding Specificity<sup>,</sup>

Jan M. Woynarowski, Cheryl Napier, Alex V. Trevino et al. · Biochemistry · 2000 · 19 citations

Tallimustine Lesions in Cellular DNA are AT Sequence-Specific but Not Region-Specific

Maryanne C. Herzig, Alex V. Trevino, Brenda Arnett et al. · Biochemistry · 1999 · 14 citations

Expression of CAAT enhancer binding protein beta (C/EBP beta) in cervix and endometrium.

Brenda Arnett, Patrick Soisson, Barbara S. Ducatman et al. · Molecular Cancer · 2003 · 14 citations · Full text

Rows per page

1–5 of 7